Florida Cancer Specialist-North

St. Petersburg, Florida 34474

1 studies enrolling now · 5 studies all time

What they study most

Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Head and Neck Cancer, MDS, Melanoma, Metastatic Pancreatic Ductal Adenocarcinoma, Monoclonal Antibody, Myelodysplastic Syndrome, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor

Studies at this site

• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now
• HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer — Completed
• CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) — Completed
• Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA — Completed